AI assistant
CVS HEALTH Corp — Director's Dealing 2015
Jan 8, 2015
29875_dirs_2015-01-08_96744243-f0d1-46f8-ba84-1f4d12a903c7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CVS HEALTH Corp (CVS)
CIK: 0000064803
Period of Report: 2015-01-07
Reporting Person: Roberts Jonathan C (EVP & President, CVS/caremark)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-08-22 | Common Stock | G | 127 | $79.24 | Disposed | 31396.9286 | Direct |
| 2015-01-07 | Common Stock | M | 86487 | $41.17 | Acquired | 117954.7177 | Direct |
| 2015-01-07 | Common Stock | S | 86487 | $95.31 | Disposed | 31467.7177 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-01-07 | Stock Option | $41.17 | M | 86487 | Disposed | 2015-04-01 | Common Stock (86487) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock (pep) | 11259.0233 | Direct |
| Common Stock (restricted) | 61443 | Direct |
| ESOP Common Stock | 7927.9129 | Indirect |
| Stock Unit | 71320.2608 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Phantom Stock Credits | $1.00 | Common Stock (1423.465) | 1423.465 | Direct | |
| Stock Option | $36.23 | 2017-04-01 | Common Stock (61196) | 61196 | Direct |
| Stock Option | $34.96 | 2018-04-01 | Common Stock (85743) | 85743 | Direct |
| Stock Option | $45.07 | 2019-04-02 | Common Stock (77639) | 77639 | Direct |
| Stock Option | $54.53 | 2020-04-01 | Common Stock (68844) | 68844 | Direct |
| Stock Option | $74.29 | 2021-04-01 | Common Stock (73433) | 73433 | Direct |
| Stock Option | $45.93 | 2022-09-04 | Common Stock (108870) | 108870 | Direct |
Footnotes
F1: All sales were effected pursuant to a Rule 10b5-1 plan.
F2: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $94.67 and $95.70 per share.
F3: Option became exercisable in three annual installments, commencing 4/1/2009.
F4: Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
F5: Option became exercisable in three annual installments, commencing 4/1/2011.
F6: Option became exercisable in four equal annual installments, commencing 4/1/2012.
F7: Option became exercisable in four equal annual installments, commencing 4/2/2013.
F8: Option became exercisable in four equal annual installments, commencing 4/1/2014.
F9: Option becomes exercisable in four equal annual installments, commencing 4/1/2015.
F10: Option becomes exercisable in three equal annual installments, commencing 9/4/2015.